Investors with the goal of beating the broader market often turn to stock selection. Strategic choices in individual stocks can have a profound impact on your wealth.
As of close of business last night, Channel Therapeutics Corporation’s stock clocked out at $1.06, down -0.93% from its previous closing price of $1.07. In other words, the price has decreased by -$0.93 from its previous closing price. On the day, 0.73 million shares were traded. CHRO stock price reached its highest trading level at $1.08 during the session, while it also had its lowest trading level at $0.91.
Ratios:
To gain a deeper understanding of CHRO’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 0.39 and its Current Ratio is at 0.39.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Sep 12 ’24 when Malamut Richard bought 10,400 shares for $0.94 per share. The transaction valued at 9,825 led to the insider holds 91,565 shares of the business.
Francis Knuettel II bought 3,500 shares of CHRO for $3,395 on Sep 13 ’24. The CEO, Pres., CFO, Treas & Secty now owns 547,710 shares after completing the transaction at $0.97 per share. On Sep 12 ’24, another insider, Francis Knuettel II, who serves as the CEO, Pres., CFO, Treas & Secty of the company, bought 1,700 shares for $0.97 each. As a result, the insider paid 1,649 and bolstered with 544,210 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CHRO now has a Market Capitalization of 6470038 and an Enterprise Value of 9363692.
Stock Price History:
The Beta on a monthly basis for CHRO is 3.78, which has changed by -0.47263682 over the last 52 weeks, in comparison to a change of 0.11241627 over the same period for the S&P500. Over the past 52 weeks, CHRO has reached a high of $3.80, while it has fallen to a 52-week low of $0.45. The 50-Day Moving Average of the stock is -26.36%, while the 200-Day Moving Average is calculated to be -5.26%.
Shares Statistics:
It appears that CHRO traded 696.15K shares on average per day over the past three months and 132500 shares per day over the past ten days. A total of 5.82M shares are outstanding, with a floating share count of 0.82M. Insiders hold about 86.60% of the company’s shares, while institutions hold 8.40% stake in the company. Shares short for CHRO as of 1745971200 were 156357 with a Short Ratio of 0.22, compared to 1743379200 on 11827. Therefore, it implies a Short% of Shares Outstanding of 156357 and a Short% of Float of 2.86.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
